首页> 美国卫生研究院文献>Experimental and Therapeutic Medicine >Part of plasmapheresis with plasma filtration adsorption combined with continuous hemodiafiltration in the treatment of severe acute liver failure
【2h】

Part of plasmapheresis with plasma filtration adsorption combined with continuous hemodiafiltration in the treatment of severe acute liver failure

机译:血浆置换结合血浆滤过吸附结合连续血液透析滤过治疗严重急性肝功能衰竭

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The present study is a retrospective analysis of 11 cases with severe acute liver failure combined with multiple organ dysfunction syndrome (MODS) performed during the period June, 2012 to December, 2014. After part of plasmapheresis with plasma filtration adsorption combined with continuous hemodiafiltration treatment, good curative effects were obtained and the main clinical symptoms and biochemical index were significantly improved. Following treatment, 8 of the 11 patients survived at a survival rate of 72.7%, and 3 patients succumbed with a mortality of 27.3%. The results suggested that part of plasmapheresis with plasma filtration adsorption combined with continuous venovenous hemodiafiltration (CVVHDF) treatment is beneficial in the removal of metabolites and toxins. Additonally, it can effectively improve liver function and clinical symptoms, improve hepatic encephalopathy, correct the disorder of internal environment, and improve the prognosis of patients.
机译:本研究是对2012年6月至2014年12月期间发生的11例严重急性肝功能衰竭并发多器官功能障碍综合征(MODS)的病例进行的回顾性分析。在部分血浆置换和血浆滤过吸附联合连续血液透析滤过治疗之后,取得了良好的疗效,主要临床症状和生化指标明显改善。治疗后,11例患者中有8例存活率为72.7%,3例患者死亡,死亡率为27.3%。结果表明,血浆置换和血浆过滤吸附结合连续静脉血液透析滤过(CVVHDF)处理对去除代谢物和毒素有益。另外,它可以有效改善肝功能和临床症状,改善肝性脑病,纠正内部环境紊乱,并改善患者的预后。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号